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Abstract 
Review on t(7;21)(p22;q22) RUNX1/USP42, with 
data on clinics, and the genes involved. 
Clinics and pathology 
Disease 
Acute myeloid leukemia M0 (M0 AML) 
Phenotype/cell stem origin 
M0 AML 
Epidemiology 
Three cases to date; a 7-year old male, a 32-year old 
male, and a 52-year old female 
Evolution 
The 7-year old male patient relapsed; however, he is 
still alive,with a bone marrow graft, 10 years after 
diagnosis. The 32-year old male died of alternative 
causes shortly after diagnosis. The female patient did 
not relapse, and is still alive. 
Disease 
Acute myeloid leukemia M4 (M4-AML) 
Phenotype/cell stem origin 
M4-AML 
Epidemiology 
Three cases to date, with the possibility of a fourth. 
Excluding fourth: 2 males (ages 39 and 13), and 1 
female (age 57). The fourth case was a 54 year old 
male with either M4 or M5 subtype. 
Evolution 
39-year old male is dead from alternative causes, no 
relapse; 57-year old female and 13-year old male are 
both alive, with no evidence of relapse. 
Disease 
Acute myeloid leukemia M5 (M5-AML) 
Phenotype/cell stem origin 
M5/M5a-AML 
Epidemiology 
Two cases with the possibility of a third (overlap 
with aforementioned M4 cases). First case is a 33-
year old male; second case is a 68-year old female. 
The third case is, as mentioned, a 54-year old male. 
Evolution 
The 33-year old male had no relapse and is still alive. 
The 68-year old female is dead, 5 years after 
diagnosis. The 54-year old male is, as mentioned, 
dead 3 months after diagnosis. 
Genes involved and 
proteins 





USP42 (ubiquitin specific protease 42), belongs to 
the ubiquitin specific protease family. Ubiquitins are 






Atlas Genet Cytogenet Oncol Haematol. 2017; 21(1) 24 
 
highly conserved proteins. Ubiquitins target proteins 
for degradation in the proteasome.  
Some USPs, however, act in the opposite reaction. 
These ubiquitin specific proteases (cysteine 
proteases) are also called deubiquitinating enzymes. 
They cleave ubiquitin from ubiquitin-conjugated 
target proteins and may lead to protein stabilization.  
Usp42 can cleave ubiquitin from ubiquitinated 
substrates. Usp42 seems to be a deubiquitinating 
enzyme.  
It may play an important role in mouse 
embryogenesis. 
RUNX1 (runt-related transcription 





Transcription factor (activator) for various 
hematopoietic-specific genes, which expression is 
limited to hematopoetic stem cells, and endothelial 
cells and mesenchymal cells in the embryo; core 
binding factor family member which forms 
heterodimers with CBFB; binds to the core site 5' 
PyGPyGGTPy 3' of promotors and enhancers 




5' RUNX1- 3' UPS42 
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